Click here to subscribe to the podcast.
On today’s episode, I’m joined by Chad Harman, Chief Executive Officer of Psycheceutical, who answers that very question and how his team at Psycheceutical is helping blaze the trail forward in this space.
Psycheceutical is focused on developing innovative solutions to society’s most pressing problems using psychedelics as medicines. Through their research, they’ve found that psychedelics are a powerful tool for treating mental health issues like depression and anxiety.
They believe that psychedelics have the potential to be used as a therapeutic aid for people with conditions such as post-traumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD), and even schizophrenia—all without the side effects of current pharmaceutical medications.
In this conversation, we discuss:
-The current state of our mental health crisis and what it’s doing to us as a society
-How psychedelic pharmaceuticals can help treat depression and other disorders
-How Psycheceutical is making this happen now instead of later
– How psychedelic medicines can help people with mental health problems
– Why there are so many misconceptions around these drugs